At Zimmer Biomet, we have invested significant time and resources to ensure our readiness for and compliance with the new European Union Medical Device Regulation (EU MDR) requirements. As a healthcare provider with diverse responsibilities, you may have questions about this complex subject. To assist our healthcare partners in navigating these changes, we have created this informative page. Our goal is to keep you informed about the modifications we are implementing in response to the EU MDR and how they will impact you. We acknowledge that there may be further changes ahead, but we remain committed to transparency and open communication.
This page provides answers to some potential questions you may have about the EU MDR. Please note that these responses offer a general overview and are not intended as guidance. For more detailed information on the changes, please visit the official EU MDR site.
The European Union Medical Device Regulation (EU MDR) replaces the previous Medical Device Directive (MDD) and introduces significant changes to the process of bringing medical devices to the European market. This new regulation aims to address life cycle aspects that were not adequately covered by the MDD. It places a strong emphasis on patient safety, standardization, and transparency.
The EU MDR aims for the highest level of patient safety while enhancing transparency and traceability throughout the life cycle of medical devices. It was established through collaboration between the European Parliament and the Council of the European Union. These regulations want to guarantee a high standard of safety and quality for medical devices in EU member countries.
The EU MDR improves the identification of medical devices and standardizes data and technological advancements through the EUDAMED database. It creates a sustainable regulatory framework that ensures health and safety while promoting innovation.
Note: The EU MDR does not include the In Vitro Diagnostic Regulation (IVDR).